Interestingly, we showed for the first time, that at the time that patients were considered as eligible for SBT, serum IL-18 levels and its relative mRNA expression increased in those recovering from sepsis and were significantly higher as compared to patients admitted for non-septic causes. The gene discussed is IL18; the disease is Sepsis.